1644 MET Exon 2 Skipping (METEx2) Mutation, a Tumor Self-Regulatory Mechanism, is Associated with Co-Existing Actionable MAP Kinase Pathway Gene Mutations, and Adverse Histology Patterns in Advanced Stage Non-Small Cell Lung Carcinomas (NSCLC): A Study of 111 Cases with METEx2 Mutation